![Yue Xing Su](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yue Xing Su
Directeur/Membre du Conseil chez
SHANGHAI MODEL ORGANISMS CENTER, INC.
Profil
Yue Xing Su currently works at Shanghai Model Organisms Center, Inc., as Director from 2020, Zhuhai Trinomab Pharmaceutical Co., Ltd., as Director from 2025, and Kangjun Investment Management (Beijing) Co. Ltd., as Senior Partner.
Postes actifs de Yue Xing Su
| Sociétés | Poste | Début |
|---|---|---|
| SHANGHAI MODEL ORGANISMS CENTER, INC. | Directeur/Membre du Conseil | 04/03/2020 |
Zhuhai Trinomab Pharmaceutical Co., Ltd.
 Zhuhai Trinomab Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology firm | Directeur/Membre du Conseil | 01/04/2025 |
Kangjun Investment Management (Beijing) Co. Ltd.
 Kangjun Investment Management (Beijing) Co. Ltd. Investment ManagersFinance Kangjun Investment Management (Beijing) Co. Ltd. is an active manager. | Private Equity Investor | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
1
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Shanghai Model Organisms Center, Inc.
 Shanghai Model Organisms Center, Inc. Miscellaneous Commercial ServicesCommercial Services Provides life science research and drug discovery services for cancer immunotherapy | Commercial Services |
Kangjun Investment Management (Beijing) Co. Ltd.
Kangjun Investment Management (Beijing) Co. Ltd. Investment ManagersFinance Kangjun Investment Management (Beijing) Co. Ltd. is an active manager. | Finance |
Zhuhai Trinomab Pharmaceutical Co., Ltd.
Zhuhai Trinomab Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology firm | Commercial Services |
